other

Updated:

Pharmascience

Pharmascience is a other based in Montreal, founded 1983; the Altss profile covers its classification, headquarters, registration, AUM band, and key contacts...

General information

Firm type

other

Year founded

1983

Location

Region

North America

Country

Canada

City

Montreal

Corporate office

Montreal, Quebec, Canada

Additional offices

New York, United States

Sector focus

Healthcare ServicesIndustrial Tech

Frequently asked questions

Who owns Pharmascience?

Pharmascience is a privately held company; its ownership is not publicly attributed to specific individuals or families. The firm was founded by a group of pharmacists and remains closely held.

Does Pharmascience operate as a family office or investment vehicle?

No. Pharmascience is an operating pharmaceutical company, not a family office. It manufactures and distributes generic and specialty drugs. Any family wealth generated from the business is managed separately and not disclosed.

What is Pharmascience's investment in R&D?

The company states it spends roughly $65 million per year on research and development, all of which is kept in Canada (per firm website, 2025). This supports its generic portfolio and Pendopharm specialty pipeline.

Is Pendopharm a separate company?

Pendopharm is a division of Pharmascience, not a separate entity. It focuses on single-source specialty drugs in gastroenterology, orthopedics, and neurology for the Canadian market.

Where does Pharmascience manufacture its products?

Pharmascience manufactures at its own facility in Montreal, Canada. This domestic production base allows the company to claim a reliable supply chain.

In how many countries does Pharmascience distribute?

Pharmascience distributes its products in over 50 countries through local distribution and commercial partnerships (per firm website, 2025).

How does Pharmascience's scale compare in the Canadian generic market?

Pharmascience claims to be the leading Canadian generic drug manufacturer by domestic market share, a position built through rapid market-share growth since its founding in 1983 (per firm website, 2025).

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Montreal other profiles